MOTION SICKNESS RELIEF- meclizine hcl tablet, chewable

Motion Sickness Relief by

Drug Labeling and Warnings

Motion Sickness Relief by is a Otc medication manufactured, distributed, or labeled by Amerisource Bergen, LNK International, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient (in each chewable tablet)

Meclizine HCl 25 mg

Purpose

Antiemetic

Uses

for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

Warnings

Do not use

for children under 12 years of age unless directed by a doctor.

Ask a doctor before use if you have

• glaucoma
• difficulty in urination due to enlargement of the prostate gland
• a breathing problem such as emphysema or chronic bronchitis

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

• drowsiness may occur
• alcohol, sedatives, and tranquilizers may increase drowsiness
• avoid alcoholic beverages
• use caution when driving a motor vehicle or operating machinery

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not take more than directed
• dosage should be taken one hour before travel starts
• chew or crush tablets completely before swallowing; do not swallow tablets whole
• adults and children 12 years and over: take 1 to 2 chewable tablets once daily or as directed by a doctor

Other information

• TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
• store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
• protect from heat and humidity
• see end flap for expiration date and lot number 

Inactive ingredients

colloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide

Questions or comments?

1-800-426-9391

Principal Display Panel

GOOD
NEIGHBOR
PHARMACY®

*Compare to the active ingredient in Bonine® Chewable Tablets

NDC: 46122-774-51

Motion Sickness Relief
Meclizine HCl 25 mg Chewable Tablets / Antiemetic

Relief for up to 24 hours

Helps Prevent Nausea, Vomiting and Dizziness
due to Motion Sickness for up to 24 hours

Ages 12 Years and Over

Chew or crush tablets
completely before swallowing.
Do not swallow tablets whole.

Raspberry Flavored
Actual Size

16 Tablets |25 mg Each

TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER
UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

Distributed By
AmerisourceBergen
1 West First Avenue
Conshohocken, PA 19428
Questions or Concerns?
www.mygnp.com

SATISFACTION
GUARANTEED

*This product is not manufactured or distributed by WellSpring
Pharmaceutical Corporation, owner of the registered trademark
Bonine® Chewable Tablets.

50844      ORG082340421

GNP 44-404A

INGREDIENTS AND APPEARANCE

MOTION SICKNESS RELIEF 
meclizine hcl tablet, chewable

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 46122-774
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570)	MECLIZINE HYDROCHLORIDE	25 mg

Inactive Ingredients
Ingredient Name	Strength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)
FD&C RED NO. 40 ALUMINUM LAKE (UNII: 6T47AS764T)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
STARCH, CORN (UNII: O8232NY3SJ)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
SACCHARIN SODIUM (UNII: SB8ZUX40TY)

Product Characteristics
Color	pink	Score	no score
Shape	ROUND	Size	9mm
Flavor	RASPBERRY	Imprint Code	44;404
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 46122-774-51	2 in 1 CARTON	03/19/2024
1		8 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M009	03/19/2024

Labeler - Amerisource Bergen (007914906)

Establishment
Name	Address	ID/FEI	Business Operations
LNK International, Inc.		038154464	pack(46122-774)

Establishment
Name	Address	ID/FEI	Business Operations
LNK International, Inc.		832867837	manufacture(46122-774) , pack(46122-774)

Establishment
Name	Address	ID/FEI	Business Operations
LNK International, Inc.		117025878	manufacture(46122-774)